Combo delays progression in relapsed CLLJune 19, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
CAR T-cell therapy seems feasible for NHL, MMJune 11, 2015Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin Lymphoma
Follow-up PET/CT has ‘clinical value’ in NHLJune 10, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
No survival difference with allo- or auto-SCT in PTCLJune 5, 2015Lymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin Lymphoma
Triplet shows early promise for relapsed CLL, NHLJune 5, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Drug prolongs PFS in indolent, refractory NHLJune 2, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Drug improves upon standard therapy for relapsed CLL/SLL, speaker saysMay 31, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hodgkin lymphoma incidence on the decline worldwideMay 29, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaNon-Hodgkin Lymphoma
Inhibitor promotes chemosensitization in CLLMay 24, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Combo targets AML, BL in the same wayMay 17, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLNon-Hodgkin Lymphoma
Study helps explain how drug fights DLBCLMay 12, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
GIST patients have higher risk of NHL, other cancersMay 8, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Inhibitor gets breakthrough designation for CLLMay 7, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
